Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy
Clinical trial NCT00780910 · COMPLETED
Trial details
- NCT number
- NCT00780910
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-10-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.